Long-term outcomes of the pay-for-performance program for patients with young-onset (20

Fu-Shun YenJames Cheng-Chung WeiYu-Tung HungChih-Cheng HsuChii-Min Hwu2026-02-022026-02-022022-1110.1016/j.diabres.2022.110136https://scholars.csmu.edu.tw/handle/123456789/4563[SDGs]SDG3Long-term outcomes of the pay-for-performance program for patients with young-onset (20–40 years of age) type 2 diabetesjournal-article